Article
p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinic-pathological correlations.
Virchows Archiv : an international journal of pathology - 1 Dec 1999
Girlando S, Slomp P, Caffo O, Amichetti M, Togni R, Dvornik G, Tomio L, Galligioni E, Dalla Palma P, Barbareschi M
Abstract excerpt
The WAF1/CIP1 gene product, p21, an inhibitor of cyclin-dependent kinases, is a critical downstream effector in the p53 pathway. The expression of p21 in human neoplasms is heterogeneous, and may be related to p53 functional status. We evaluated p21 immunoreactivity in 103 colorectal carcinomas (CC) in relation to the p53 gene and protein alterations and clinico-pathologic parameters. High p21 expression (more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
